Tumor-promoting action of sympathetic nerves has been ascribed to the adrenergic signaling, as many cancer cells express both the β1- and β2-adrenergic receptors (ARs), and high-grade tumors show higher levels of β-ARs compared to lower-stage diseases (10–12). Here, CTBP1 is linked to neoplasm.